School of Medicine
Showing 101-150 of 242 Results
-
Husham Sharifi
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioI am a Clinical Assistant Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine in Stanford University School of Medicine. In addition to seeing patients in the intensive care unit (ICU), I focus my research and clinical practice on transplant-related pulmonary fibrosis, which includes fibrotic lung disease after lung transplant or after hematopoietic cell transplant. My research applies advanced computational analysis to clinical metadata and quantitative imaging data, domains that draw on my training in engineering and bioinformatics. In the clinical setting I see patients in a Lung Graft-versus-Host-Disease (GVHD) Clinic for individuals with pulmonary complications after life-saving hematopoietic cell transplant. Our clinic is part of a national Lung GVHD Consortium comprising Stanford, Fred Hutchinson Cancer Center, University of Michigan, and MD Anderson Cancer Center. In this context I am the site co-Principal Investigator for two national clinical trials through the Lung GVHD Consortium that are funded by the National Institutes of Health. The first trial uses a home spirometry device and monitoring system to study the association of Lung GVHD with respiratory viral infections. The second trial studies the diagnostic and prognostic utility of quantitative CT scans of the chest for Lung GVHD. My goal is to fuse detailed, communicative patient care with the advances of data science in medicine that I research and study.
-
Disha Sharma
Postdoctoral Scholar, Cardiovascular Medicine
BioI am a computational biologist with more than 12 years of extensive experience aiming to pursue career in developing translational medicine- and healthcare-oriented solutions. I have Ph.D. in bioinformatics with technical expertise for next-generation sequencing assays, genome-wide association studies, bulk and single-cell multi-omics analysis, R, python, shell Scripting, cloud computing, Data structure and algorithms, as well as machine and deep learning algorithms. I have solid background in genomics, transcriptomics, epigenomics and metagenomics. I have worked with both complex and rare genetic disorders performing data analysis, data interpretation, data curation with clinical data and databases.
I am presently a postdoctoral fellow at Stanford University for 4 years now where my main focus is to understand the genetic risks of cardiometabolic diseases using GWAS, integrating modalities including single-cell multiomics, CRISPR perturbation datasets. I am working on building machine learning models and use statistical genetics tools using large biobanks including UKBiobank, AllofUS and MVP. -
Rahul P Sharma, MBBS, FRACP
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsTranscatheter valve therapies, CT valve imaging, AI and device innovation
-
Christopher Sharp, MD
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsClinical Informatics
Clinical Education
Teaching Physical Examination
Quality Improvement
Preventive Medicine -
Sumana Shashidhar
Associate Director, Clinical Research Operations, Med/Stanford Center for Clinical Research
Current Role at StanfordAssociate Director - Clinical Research Operations
Stanford Center for Clinical Research -
Heather Shaw RN, MS, GNP-BC
Affiliate, Primary Care and Population Health
BioHeather is a board certified geriatric nurse practitioner with 20 years of experience. She has practiced in multiple settings including home based primary care, ambulatory clinics, and acute care. In addition to clinical practice, Heather enjoys participating in research, publications, quality improvement and education. Heather is currently the operational manger of the Inpatient Palliative Medicine and Inpatient Geriatric Consult teams.
-
Jonathan Shaw
Clinical Professor, Medicine - Primary Care and Population Health
Clinical Professor (By courtesy), Obstetrics & GynecologyCurrent Research and Scholarly InterestsPrimary care, psycho-social determinants of health & care, maternal-child health
-
Edward Sheen
Adjunct Professor, Medicine - Med/Gastroenterology and Hepatology
BioDr. Edward Sheen is Chief Quality and Population Health Executive for L.A. Care. Serving more than 2.9 million members, L.A. Care is the largest publicly operated health plan in the country. As a public entity, its mission is to provide access to quality care for vulnerable and low-income communities and to elevate the safety net. Previously, he was Chief Population Health Officer, Senior Vice President for Health Catalyst and Chief Medical Officer, Market Development and Solution Design for Lumeris, a leading value-based care technology and services operator as well as 5.0 Star Medicare Advantage plan. He has worked with health systems and payers across the country to improve health outcomes, enhance patient experience, strengthen care provider engagement, reduce costs of care, and accelerate their journey towards accountable care. He is dedicated to achieving accessible, equitable, person-centered, and high-performing care for all.
Dr. Sheen’s experience has bridged the public, private, non-profit, and academic sectors and additionally includes work with Stanford University, the White House, U.S. Department of Defense, U.S. Department of Health and Human Services, California State Assembly, Kaiser Family Foundation, Blue Shield, California and American Medical Associations, and Genzyme. In 2014, he was one of 15 Americans appointed by President Obama a nonpartisan White House Fellow. He subsequently served as a Special Assistant to the Secretary of Defense and Defense Department senior health policy advisor and was a recipient of the Office of the Secretary of Defense Medal for Exceptional Public Service. Dr. Sheen was a Term Member of the Council on Foreign Relations. He currently serves on the National Advisory Council on the National Health Service Corps, which advises the Secretary of Health and Human Services. He is Adjunct Professor of Medicine and Global Health Faculty Fellow at Stanford. He has a long-standing active commitment to mentoring, teaching, and medical education.
Dr. Sheen completed his Internal Medicine and Gastroenterology training at Stanford, received his MD from the University of California, San Francisco, and earned his MBA and MPH through scholarships from Stanford Graduate School of Business and Harvard School of Public Health, where he was also a Harvard Kennedy School Center for Public Leadership Zuckerman Fellow. He graduated magna cum laude from Brown University with a B.A. in Public Policy and induction into Phi Beta Kappa. -
Meera Sheffrin
Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsGeriatric education
Implementation and evaluation of home-based care
Improving care for older adults with dementia -
Margarette Jeannette Shegog
Affiliate, Primary Care and Population Health
BioDoctor Margarette J. Shegog is board-certified by the American Board of Family Medicine and has a special interest in mental health care, obstetrics, LGBTQIA care (including gender affirming care), and the decolonization of medicine. As a full scope Family medicine doctor, she enjoys serving her community in the clinic, hospital and delivering babies. She also has and fellowship in Behavioral Health and Psychiatry. Dr Shegog loves connecting with nature as well as others and can be found on a hiking trail, in the theater, dancing with her daughter, or playing tabletop games with her friends and family.
-
Bansari Sureshchandra Sheth
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Sheth is originally from southern California, but has progressively moved up the coast over the last few years, now making the Bay Area her wonderful new home. Board certified in Family Medicine, she had comprehensive training during residency. She has a variety of special interests, including pediatric illnesses, women’s health, diabetes care including lifestyle management, as well as Hepatitis C treatment. She believes in empowering her patients, working together with them as a team. In her free time, Dr. Sheth enjoys yoga, going to plays or musicals, comedy shows, and hiking.
-
Parveen Shiraz, MD
Instructor, Medicine - Blood & Marrow Transplantation
Current Research and Scholarly InterestsI am a physician-scientist in the Division of Blood and Marrow Transplantation-Cell Therapy (BMT-CT) at Stanford University. The focus of my laboratory research is the exploration of safe and more accessible forms of cell therapy for myeloid malignancies. We are studying multi-antigen targeting antibodies and engineered Natural Killer cells for myeloid malignancies.
-
Judith Shizuru
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsTransplantation of defined populations of allogeneic hematopoietic cells. Specifically, the way in which hematopoietic cell grafts alter antigen specific immune responses to allo-, auto- and viral antigens. The cellular and molecular basis of resistance to engraftment of allogeneic hematopoietic stem cells.
-
William Shomali
Clinical Assistant Professor, Medicine - Hematology
BioDr. Shomali is a clinical assistant professor of Hematology at Stanford University School of Medicine. He is board certified in hematology & medical oncology.
Dr. Shomali specializes in the treatment of blood cancers such as myeloproliferative neoplasms and myelodysplastic syndromes. He aims to provide compassionate, personalized, and evidence-based care to each patient.
Dr. Shomali received his medical degree from the University of Jordan, followed by a postdoctoral fellowship at MD Anderson Cancer Center where he studied infections in cancer patients and the role of biomarkers in defining tumor fever. He completed his residency training in Internal Medicine at the Cleveland Clinic Foundation where he served as a Chief Medical Resident. He then joined Stanford University for his combined Hematology & Oncology fellowship training.
Dr. Shomali’s research interests include the study of novel agents in myeloproliferative neoplasms and myelodysplastic syndromes. He developed investigator-initiated clinical trials for patients with eosinophilic neoplasms and advanced myelofibrosis. In addition, he co-authored several papers and book chapters discussing the care of patients with cancer. His work has been presented in national meetings and published in peer reviewed journals including Blood, American Journal of Hematology, British Journal of Hematology, Leukemia & Lymphoma, and Cancer.
Among his honors, Dr. Shomali received the Cleveland Clinic Excellence in Teaching Award and was named to the Alpha Omega Alpha Medical Honor Society. He has received a Young Investigator Award from the Conquer Cancer Foundation, an NIH Institutional National Research Service Award, and a Stanford Cancer Institute Fellowship Award.
Dr. Shomali is a member of the American Society of Hematology and the American Society of Clinical Oncology. -
Stanford Shoor
Clinical Professor, Medicine - Immunology & Rheumatology
Current Research and Scholarly InterestsPatient Centered Care in Rheumatic Disease
Sarcoidosis -
Aimee D. Shu
Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioI am an endocrinologist with particular interests in reproductive and bone health.
I enjoy treating patients with menstrual disorders, menopause, fractures, osteoporosis, parathyroid imbalance, and calcium imbalance.
As a certified menopause practitioner (North American Menopause Society), I help women fine-tune their health at the mid-life transition. Some women transition through menopause with ease, while others experience challenging symptoms like hot flashes, slowed metabolism, and mood changes. This transition period provides a good opportunity to create a "game plan" for preserving future health. It also marks the beginning of natural bone loss, leaving one more susceptible to fragility fractures.
I provide individualized treatment plans for bone health to men and women of all ages, including for those with specific challenges such as chronic steroid use. As a certified clinical densitometrist (International Society for Clinical Densitometry), I personally review all my patients' bone density scan images. Thus, please bring any non-Stanford bone density scan images to your appointment with me.
Appointments with me are available on Stanford's main campus (300 Pastuer Drive) and at the Stanford Medicine Outpatient Center (450 Broadway, Redwood City). -
Takudzwa Shumba
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Takudzwa Shumba is a family medicine clinician-educator with particular interests in global health equity, preventative medicine, women's health, pediatrics and integrative medicine. She was born and raised in Zimbabwe. Prior to beginning medical school at Stanford, she completed a Master's in Public Health at Yale, with a focus in global health. She has been involved in public health projects in Zimbabwe, Hong Kong and mainland China and Kenya. She completed her residency at Stanford Health Care - O'Connor Hospital Family Medicine in San Jose, prior to joining faculty at Stanford Family Medicine. LGBTQQI friendly. After several years as a continuity primary care provider at Stanford Family Medicine, she transitioned to providing quality same day access for acute patient needs.
She is currently Co-director of the Leadership Education in Advancing Diversity (LEAD) program, Associate Director of the Clinical Summer Internship (CSI), Course Director of the undergraduate seminar “Decolonizing Global Health,” and Co-Director of the "Social and Environmental Determinants of Health" elective. She is a California Health Care Foundation (CHCF) Fellow (2020-2022) and Presidential Leadership Scholar (2022). She previously served as the Primary Care and Population Health (PCPH) Division Global Health faculty lead and PCPH DEI faculty lead. -
Anjali Sibley MD, MPH
Clinical Associate Professor, Medicine - Oncology
BioDr. Sibley is a Clinical Associate Professor of Medicine (Oncology) at Stanford School of Medicine. She is the Director of the Stanford Medicine Cancer Center in Emeryville and is a board-certified, fellowship-trained hematologist and medical oncologist.
Her clinical interests include treating solid tumor cancers, lung cancers, blood cancers and benign blood conditions. She is interested in cancer prevention and reducing disparities in hematologic/oncologic care among underserved populations, and successful cancer survivorship programs.
In addition to responsibilities related to patient care and overseeing the Cancer Center in Emeryville, Dr. Sibley has developed and is leading an innovative cancer survivorship clinic, including an exercise initiative. She also is passionate about advancing clinical trial enrollment for medically underserved populations and she serves on the Cancer Network’s East Bay Health Equity Committee leading lung cancer screening efforts in the East Bay. She is also working on a Stanford Cancer Institute-funded study examining psychosocial factors and cardiac health in Black cancer patients in the East Bay.
She believes that providing patient care is a true privilege. Dr. Sibley utilizes a patient-centered practice approach that addresses multiple aspects of a patient’s well-being. Her research interests have included chemoprevention of breast cancer and the development of magnetic resonance imaging technology in breast cancer detection and mapping. She has also led community-based efforts to implement low-dose computed tomography (LDCT) as a screening tool for cancer.
Dr. Sibley’s publications include articles on breast cancer prevention, breast magnetic resonance imaging, and other topics. Her work has appeared in American Journal of Hematology, JAMA, the Breast Journal, Internal Medicine News, and elsewhere. Dr. Sibley was invited to deliver a peer-reviewed presentation on community-based cancer screening and preventive education to the Global Health Council. Dr. Sibley is on the board of directors of the Cancer Support Community SF Bay Area. She has also served as a clinic physician for the Native American Health Center of Oakland, on the Committee on Health Equity of the American Public Health Association, and as chair and vice chair of the Cancer Forum Caucus of the American Public Health Association. She is a member of the American Society of Clinical Oncology, American Society of Preventive Oncology, and American Society of Hematology. She has provided volunteer services to the Global Health Council and to the Cancer Patients Aid Association, for whom she conducted a patient screening and education program in Mumbai, India. -
Surbhi Sidana, MD
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Surbhi Sidana is an Associate Professor of Medicine at Stanford University and specializes in the treatment of multiple myeloma and related disorders. She leads the Myeloma CAR-T/Immunotherapy program at Stanford.
Dr Sidana grew up in Delhi, India, where she completed her initial medical training. She then moved to the U.S and completed her Internal Medicine Residency at Cleveland Clinic in Cleveland, Ohio, followed by Hematology/Oncology fellowship at Mayo Clinic in Rochester, MN. Following this, she completed an Advanced Hematology Fellowship in Myeloma, Amyloidosis and Related Disorders at Mayo Clinic in Rochester, MN before joining Stanford University as a faculty member in 2019, where she has led the development of the myeloma CAR-T and bispecific antibody program.
Dr Sidana has an active, broad research portfolio that includes clinical trials of novel therapies in myeloma and related disorders, translational research, epidemiologic and patient reported outcome studies. She has a special focus on research with immunotherapies such as CAR-T cell therapy and bispecific antibodies. She has published over 80 research manuscripts. Dr Sidana is the Leader of the Myeloma Disease Focused Group and the Associate Director for Clinical Research in the BMT and Cell Therapy Division at Stanford University. She also co-leads a multi-institutional collaboration on real world outcomes with immunotherapies in myeloma.
Dr Sidana is actively involved in and holds leadership positions in national and international professional societies. She co-chairs the Quality-of-Life Committee of the International Myeloma Working Group and is the Vice-Chair of the American Society of Hematology Committee on Communications. She also a member of the ASH Editor Search Committee and the SWOG Myeloma Committee. -
Pradeep Kumar Siddappa, MD
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Pradeep Kumar Siddappa is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care. He is also a clinical assistant professor in the Department of Medicine, Division of Gastroenterology & Hepatology at Stanford University School of Medicine.
Dr. Siddappa specializes in advanced endoscopy procedures to diagnose and treat gastrointestinal conditions. He focuses on pancreatic care, including acute and chronic pancreatitis, pancreatic cysts, and pancreatic cancer. He uses advanced, minimally invasive methods to help detect pancreatic cancer early and treat people who cannot undergo surgery.
Dr. Siddappa has studied many gastrointestinal conditions over the years, garnering grant funding and several awards. His primary research examines pancreatic cancer and how to catch it earlier through biomarkers in the pancreatic cyst fluid. He also investigates ways to improve endoscopic and duodenoscopic technology. He has developed new endoscopic techniques for diagnosis and treatment, including endoscopic ultrasound-guided omental fine needle aspiration.
Dr. Siddappa has published his findings in peer-reviewed journals including the Journal of Gastrointestinal Cancer, Clinical Endoscopy, JGH Open, and the World Journal of Gastrointestinal Endoscopy. He has also shared his research and presented it at conferences around the world, including at the annual Digestive Diseases Week. He has covered topics including new diagnostic markers in pancreatic cyst fluid, narrow band imaging, hepatocellular carcinoma, and pancreatic ductal adenocarcinoma.
Dr. Siddappa is a member of the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. -
Branimir I. Sikic, M. D.
Professor of Medicine (Oncology), Emeritus
Current Research and Scholarly InterestsResearch Interests: cancer pharmacology, mechanisms of resistance to anticancer drugs, regulation and function of MDR1 and tubulin genes, CD47 as a target for activation of anticancer macrophases, Phase I trials of new drugs, gene expression profiling of cancers
-
Julia Fridman Simard
Associate Professor of Epidemiology and Population Health, of Medicine (Immunology & Rheumatology) and, by courtesy, of Obstetrics and Gynecology (Maternal Fetal Medicine)
BioJulia Fridman Simard, ScD, is an Associate Professor of Epidemiology & Population Health, and of Medicine in Immunology and Rheumatology and Obstetrics and, by courtesy, Gynecology in Maternal Fetal Medicine at Stanford University School of Medicine.
Dr. Simard earned her Masters and Doctorate of Science in Epidemiology degrees at the Harvard School of Public Health. During that time she trained with investigators at the Section of Clinical Sciences, Division of Rheumatology, Immunology, and Allergy at Brigham and Women’s Hospital and the Cardiovascular Epidemiology Research Unit at Beth Israel Deaconess Medical Center. In 2008, Dr. Simard relocated to Sweden to begin a Postdoctoral Fellowship in Clinical Epidemiology at the Karolinska Institutet in Stockholm. She became an Assistant Professor in their Clinical Epidemiology Unit in 2011, and was later honored with a Karolinska Institutet Teaching Award. Leveraging the population-based registers of Sweden, Dr. Simard initiated a national register linkage study to examine the utility of registers in Systemic Lupus Erythematosus (SLE) research and develop an extensive data repository for future epidemiologic investigations.
While maintaining a close collaboration with the Karolinska Institutet, she joined Stanford’s Epidemiology faculty in 2013. Dr. Simard studies outcomes such as malignancy, stroke, infection, and mortality, in patients with systemic autoimmune rheumatic diseases with a focus on systemic lupus erythematosus. Recently her primary research focus has shifted to the intersection between reproductive epidemiology and rheumatic disease fueled by a K01 career development award from the NIH (NIAMS) to study maternal and fetal outcomes in systemic lupus pregnancy. This led to collaborations with colleagues at Stanford, throughout the US, and abroad, and a series of projects focused on the diagnosis of preeclampsia and associated risks in pregnant women with systemic lupus. Dr. Simard was awarded a Peter Joseph Pappas Research Grant from the Preeclampsia Foundation for her lab's work examining preeclampsia risk in high-risk populations, and a McCormick Faculty Award from Stanford Medicine to take important steps towards disentangling preeclampsia from lupus nephritis. Dr. Simard is leading an international study of hydroxychloroquine in lupus pregnancy leveraging mixed methods in partnership with qualitative researchers, patients, clinicians, and epidemiologists in Sweden, Canada, and in the United States.
In addition to these issues of misclassification in reproductive rheumatology questions, Dr. Simard's lab is also interested in how misclassification, missed opportunities, and misdiagnosis contribute to disparities in complex conditions such as systemic lupus. In addition to methodologic issues around misclassification and bias and the largely clinical epidemiology focus of her work, Dr. Simard's work examines social determinants of health and health disparities. Dr. Simard was recently awarded an R01 from NIH (NIAID) to study the role of cognitive and unconscious bias in clinical decision making for female-predominant diseases including lupus.
